Compare PDSB & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | MYO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 36.9M |
| IPO Year | 2015 | 2017 |
| Metric | PDSB | MYO |
|---|---|---|
| Price | $0.66 | $0.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $9.00 | $7.67 |
| AVG Volume (30 Days) | ★ 370.9K | 354.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.90 | ★ 42.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.60 | $0.64 |
| 52 Week High | $1.90 | $6.27 |
| Indicator | PDSB | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 48.75 |
| Support Level | $0.60 | $0.74 |
| Resistance Level | $1.16 | $1.03 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 43.70 | 72.68 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).